Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil once-daily for benign prostatic hyperplasia and erectile dysfunction (Phase 3)
KCT0001109Phase 3Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil in benign prostatic hyperplasia (BPH), erectile dysfunction (ED), sponsored by Eli Lilly and Company. Started Sep 2013; status: recruiting.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)erectile dysfunction (ED)
Beyond the preview
Go deeper on KCT0001109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001109.